Prognostic Value and Efficacy Evaluation of Novel Drugs for Multiple Myeloma Patients with 1q21 Amplification (Amp1q21) Only: A Systematic Review of Randomized Controlled Trials

Background: Multiple myeloma (MM) is a heterogeneous disease characterized by chromosomal translocation, deletion, and amplification in plasma cells, resulting in a huge heterogeneity in its outcomes. Of all these cytogenetic abnormalities, Amp1q21 is most commonly detected, which is always associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Li, Zhendong, Li, Shanshan, Fu, Weijun, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066010/
https://www.ncbi.nlm.nih.gov/pubmed/32201534
http://dx.doi.org/10.7150/jca.40711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066010/
https://www.ncbi.nlm.nih.gov/pubmed/32201534
http://dx.doi.org/10.7150/jca.40711

Ejemplares similares